Publication date: October 2026 Source: Seminars in Arthritis and Rheumatism, Volume 80 Author(s): Abdurrahman Tufan, Deborah L. Stone, Tina Romeo, Patrycja Hoffmann, Lorena Wilson, Natalie T. Deuitch, Christina Kozycki, Kalpana Manthiram, Sarah Hansen, Daniel L. Kastner, Amanda K. Ombrello
Biologic–biologic and biologic–JAK inhibitor combination therapy in refractory systemic autoinflammatory diseases. // Seminars in Arthritis and Rheumatism. – URL: https://www.sciencedirect.com/science/article/pii/S0049017226001575?dgcid=rss_sd_all
Biologic–biologic and biologic–JAK inhibitor combination therapy in refractory systemic autoinflammatory diseases. Seminars in Arthritis and Rheumatism. https://www.sciencedirect.com/science/article/pii/S0049017226001575?dgcid=rss_sd_all
“Biologic–biologic and biologic–JAK inhibitor combination therapy in refractory systemic autoinflammatory diseases.” Seminars in Arthritis and Rheumatism.
@article{article65790,
title = {Biologic–biologic and biologic–JAK inhibitor combination therapy in refractory systemic autoinflammatory diseases},
journal = {Seminars in Arthritis and Rheumatism},
url = {https://www.sciencedirect.com/science/article/pii/S0049017226001575?dgcid=rss_sd_all}
}